Adam Maeder

Joshua Jennings

Ryan Zimmerman

Eric Anderson

Josh Jennings

- **Vicarious Surgical Inc.** announced the pricing of a registered direct offering and a concurrent private placement on **October 8, 2025**.  **[1812173_0001213900-25-097471_ea026066701ex99-1_vicarious.htm:0]** 
- The company expects to receive approximately **$5.9 million** in gross proceeds from these offerings.  **[1812173_0001213900-25-097471_ea026066701ex99-1_vicarious.htm:0]** **[1812173_0001213900-25-097471_ea0260667-8k_vicarious.htm:1]** 
- The offering includes the sale of **1,150,000 shares** of Class A common stock (or pre-funded warrants in lieu thereof) and warrants to purchase an aggregate of **2,300,000 shares** of Class A common stock (Series A and Series B warrants).  **[1812173_0001213900-25-097471_ea026066701ex99-1_vicarious.htm:0]** **[1812173_0001213900-25-097471_ea0260667-8k_vicarious.htm:1]** 
- The combined effective purchase price for one share of Class A common stock and accompanying warrants to purchase two shares of Class A common stock is **$5.10**.  **[1812173_0001213900-25-097471_ea026066701ex99-1_vicarious.htm:0]** 
- The proceeds are intended for general corporate purposes, which may include working capital, capital expenditures, or research and development expenditures.  **[1812173_0001213900-25-097471_ea026066701ex99-1_vicarious.htm:0]** **[1812173_0001213900-25-097471_ea026066701ex10-1_vicarious.htm:33]**

Vicarious Surgical Prices $5.9 Million Offering

- **Vicarious Surgical** announced a registered direct offering and concurrent private placement, expecting to raise approximately **$5.9 million** in gross proceeds.  **[1812173_e519407e6e32462980aece8a16bcb6fa_0]** 
- The offering involves the sale of **1,150,000 shares of Class A common stock** (or pre-funded warrants) and the issuance of warrants to purchase an aggregate of **2,300,000 shares** of Class A common stock.  **[1812173_e519407e6e32462980aece8a16bcb6fa_0]** 
- The combined effective purchase price for one share of Class A common stock and accompanying warrants to purchase two shares is **$5.10**, with the Common Warrants having an exercise price of **$5.10 per share**.  **[1812173_e519407e6e32462980aece8a16bcb6fa_0]** 
- The company plans to use the proceeds for **general corporate purposes**, which may include working capital, capital expenditures, or research and development expenditures.  **[1812173_e519407e6e32462980aece8a16bcb6fa_0]** 
- The offering is expected to close on or about **October 9, 2025**.  **[1812173_e519407e6e32462980aece8a16bcb6fa_0]** **[1812173_e519407e6e32462980aece8a16bcb6fa_1]**

Vicarious Surgical (RBOT)